HER2-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 2

Featuring perspectives from Dr Sara Tolaney, including the following topics: Introduction: DESTINY-Breast03 (0:00) Case: A woman in her early 50s with ER/PR-negative, HER2-positive breast cancer with bone, lung, liver and brain metastases — Justin Peter Favaro, MD, PhD (14:02) Case: A woman in her mid-70s with ER-positive, PR-negative, HER2-positive metastatic breast cancer — Sulfi Ibrahim, MD (18:38) Case: A woman in her early 60s with a localized 3.5-cm weakly ER/PR-positive, HER2-positive, node-negative breast cancer — Andrea Stebel, MD (28:18) Case: A woman in her early 40s with localized ER-negative, HER2-positive breast cancer — Ann Partridge, MD, MPH (31:04) Case: A woman in her early 40s with localized ER-positive, HER2-positive breast cancer — Kelly Yap, MD (36:26) Case: A woman in her late 30s with ER/PR-positive, HER2-positive, node-positive inflammatory breast cancer — Benjamin Parsons, DO (46:29) CME information and select publications